← Back to home

Virologically suppressed HIV-1 infection receiving long-acting antiretroviral therapy

Clinical trials for Virologically suppressed HIV-1 infection receiving long-acting antiretroviral therapy explained in plain language.

Never miss a new study

Get alerted when new Virologically suppressed HIV-1 infection receiving long-acting antiretroviral therapy trials appear

Sign up with your email to follow new studies for Virologically suppressed HIV-1 infection receiving long-acting antiretroviral therapy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New study checks if Long-Acting HIV shots work for all subtypes

Disease control Recruiting now

This study looks at how well a long-acting injectable HIV treatment works in people with HIV-1 subtype A6, a common type in Eastern Europe. Researchers will compare medical records from 250 adults in Poland, Germany, and the Czech Republic who have already received the shots. The…

Matched conditions: VIROLOGICALLY SUPPRESSED HIV-1 INFECTION RECEIVING LONG-ACTING ANTIRETROVIRAL THERAPY

Sponsor: Pomeranian Medical University Szczecin • Aim: Disease control

Last updated Jun 27, 2026 13:06 UTC

Virologically suppressed HIV-1 infection receiving long-acting antiretroviral therapy

Get alerted when new Virologically suppressed HIV-1 infection receiving long-acting antiretroviral therapy trials appear

New study checks if Long-Acting HIV shots work for all subtypes